Aeglea BioTherapeutics (NASDAQ:AGLE) Earnings Information
Aeglea BioTherapeutics last posted its earnings data on March 17th, 2021. The biotechnology company reported ($0.35) EPS for the quarter, missing the consensus estimate of ($0.31) by $0.04. Aeglea BioTherapeutics has generated ($2.45) earnings per share over the last year. Aeglea BioTherapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 6th, 2021 based off prior year's report dates.
Aeglea BioTherapeutics Earnings Estimates and Actuals by Quarter
The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.
Aeglea BioTherapeutics (NASDAQ:AGLE) Earnings Estimates
2021 EPS Consensus Estimate: ($1.62)
Aeglea BioTherapeutics (NASDAQ AGLE) Earnings History by Quarter
(Earnings results data provided by Zacks Investment Research)